OCT in Open Fracture and Infected Fracture
Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · Mar 14, 2023
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help doctors see inside bones that have been broken or are infected, using a method called Optical Coherence Tomography (OCT). OCT is a light-based imaging technique that doesn’t require any medication or special dyes, making it easier and safer for patients. The study aims to find out if this method is practical and acceptable for patients with open fractures or fractures that have become infected.
To participate, you need to be at least 18 years old and have either an open fracture or a fracture that is infected. Unfortunately, if you have a specific type of fracture in the foot called a metatarsal fracture, you wouldn’t be eligible to join. If you decide to participate, you can expect to undergo the OCT imaging as part of your treatment process, and the study will help researchers learn more about how effective this imaging technique can be for future patients. The trial is currently recruiting participants of all genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or older
- • Open fracture
- • Fracture Related Infection
- Exclusion Criteria:
- • Metatarsal fractures
About Dartmouth Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center (DHMC) is a leading academic medical institution located in Lebanon, New Hampshire, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a major teaching hospital affiliated with the Geisel School of Medicine at Dartmouth, DHMC integrates cutting-edge clinical trials and translational research into its comprehensive patient care approach. The center emphasizes collaboration across disciplines, aiming to enhance patient outcomes through rigorous scientific investigation, education, and community engagement. With a focus on ethical practices and patient safety, DHMC is dedicated to contributing to the advancement of medical knowledge and improving health care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lebanon, New Hampshire, United States
Lebanon, New Hampshire, United States
Patients applied
Trial Officials
Ida L Gitajn
Principal Investigator
Dartmouth-Hitchcock Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials